Featured
Last news
Sri Lanka Catholics seek prosecution of sacked spy chief
Sri Lanka's Catholic Church on Monday demanded the criminal prosecution of the intelligence chief who was sacked for failing to prevent the 2019 Easter bombings that killed 279 people, including 45 foreigners.
World's major courts take growing role in climate fight
The world's top court is poised to tell governments what their legal obligations are to tackle global warming, and possibly outline consequences for polluters that cause climate harm to vulnerable countries.
Trump and Epstein: What was their relationship?
Donald Trump's past ties with Jeffrey Epstein are under scrutiny after the US president slammed a Wall Street Journal report that he sent a lewd letter to the infamous sex offender as "fake news."
New to The Street Episode #679 Airs Tonight on Fox Business Network
Featuring Hapbee Technologies (HAPBF), Arrive AI (ARAI), FLOKI, BioVie Pharma (BIVI) & The Sustainable Green Team (SGTM)
INY Books Sets August 29, 2025 As Release Date For Acclaimed Children's Author Emberli Pridham's Newest Book In Her Celebrated A Real Life Fairy Tale Series - A Real Life Fairy Tale: Princess Kate
Little did Kate Middleton dream about her future as a global figure, but the young girl from Reading, England was destined to become a treasured member of the Royal Family and a beloved symbol of hope and inspiration for her countryPrincess Kate follows Princess Diana, Princess Grace and Jackie Kennedy as subjects for Emberli Pridham's popular biography series for children
CASI Pharmaceuticals Appoints David Cory as Chief Executive Officer to Lead U.S. Company Focused on Clinical Development of CID-103, a Potential Best in Class Anti-CD38 Program
-- David Cory is an industry veteran, bringing more than 30 years of operational experience, in private and public, emerging-stage biotech and large pharma companies with an established track record of building and leading high performing operating teams and financing in the capital markets with over $1B+ raised and multiple company exits by acquisition-- CID-103 is a potential best in class, anti-CD38 monoclonal antibody, currently dosing in a multi-center Phase 1/2 study in adults with chronic immune thrombocytopenia (ITP); IND submitted to support future clinical trials in adults with renal allograft antibody-mediated rejection (AMR)
BGSF, Inc. Announces Timing of Fiscal 2025 Second Quarter Results and Earnings Conference Call
PLANO, TX / ACCESS Newswire / July 21, 2025 / BGSF, Inc. (NYSE:BGSF), a growing provider of consulting, managed services, and workforce solutions, today announces that it will release its fiscal 2025 second quarter results on Wednesday, August 6, 2025, after the market close. In conjunction with the release, management will host an earnings conference call, a live teleconference, and a webcast at 9:00 am ET on Thursday, August 7, 2025.
Harrison Global Holdings Inc. Commences Due Diligence for Subsidiary Acquisition and Strategic Partnership with Idealize Co., Ltd.
TOKYO, JAPAN / ACCESS Newswire / July 21, 2025 / Harrison Global Holdings Inc. (NASDAQ:BLMZ) ("Harrison Global" or the "Company"), a Japanese audio production, VTuber, entertainment, and voice actor management company, announced it has commenced due diligence procedures for a planned subsidiary acquisition and strategic business partnership with Idealize Co., Ltd. ("Idealize"), a Japanese event operations, audio and visual production company.
Noble Roman's Introduces Xtra-Stuffed Crust Pizza!
Featuring Over Double the Cheese and Free Buttery Garlic Dipping Sauce
SOHM, Inc. Launches New User-Friendly Website to Enhance Customer, Investor Experience and Engagement
CHINO HILLS, CALIFORNIA / ACCESS Newswire / July 21, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading innovator in pharmaceuticals, nutraceuticals, topicals, and biotechnology, is excited to announce the launch of its newly designed website, now live at SOHM.com (https://sohm.com). This refreshed online presence aims to better serve customers, collaborators, and investors with an intuitive interface, improved navigation, more information, and enhanced features.
SMP Nutra Officially Cuts Ribbon For Their New Headquarters In Florida
A state‑of‑the‑art, 100,000+ square‑foot facility in Largo, Florida, will serve as the company's new operational hub.
LeBron Jersey Fetches $242K as MDCE's Subsidiaries Hit Growth Stride
MESA, ARIZONA / ACCESS Newswire / July 21, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) is pleased to announce that its wholly owned subsidiary, Infinite Auctions, has completed the sale of a LeBron James 2014 NBA Finals Game-Worn Miami Heat Jersey for $242,400. The jersey was worn by James in Game 4 of the 2014 NBA Finals, marking his final home game as a member of the Miami Heat.
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025
HACKENSACK, NJ / ACCESS Newswire / July 21, 2025 / Champions Oncology, Inc. (CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the quarter and year ended April 30, 2025, on Wednesday, July 23, 2025, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EDT (1:30 P.M. PDT). To join the call dial 888-506-0062 (Domestic) or 973-528-0011 (International) and enter the access code 792442. A replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering passcode: 52754, or by accessing the investors section of the company's website within 72 hours.
RMTG Expands to Puerto Rico with New Affiliate Partnership
Strategic Alliance Adds High-Value Territory to Global Network of 26 Clinics
Protagonist Announces Submission of NDA for First Icotrokinra U.S. FDA Approval Aiming to Revolutionize Treatment Paradigm for Adults and Adolescents with Plaque Psoriasis
Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptorFiling based on unprecedented data package that met all primary endpoints across four Phase 3 studies, including head-to-head superiority comparisons versus deucravacitinib and evaluation of difficult to treat skin sitesSubmission underscores potential to offer moderate-to-severe plaque psoriasis patients the standout combination of complete skin clearance, favorable safety profile, and simplicity of a once-daily pill
Measles Now Has a Drug - NV-387 Broad-Spectrum Antiviral Successful in Animal Studies, says NanoViricides
SHELTON, CT / ACCESS Newswire / July 21, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.: NNVC ) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, announced that it has achieved significant success in developing a drug against Measles.
Evotec Adjusts Revenue Guidance and Confirms Profit Guidance Anticipating a More Profitable Revenue Mix
Successful execution of new strategy for sustainable and profitable growth leading to changing revenue mix with strong demand for Evotec's differentiated platformsHigh-margin technology license revenues expected to have a stronger impactthan anticipatedSignificant cost optimization in excess of initial targets from Priority ResetShared R&D base businesscontinues to navigate in a challenging market environmentH1 2025 Group revenues below expectations; adj. EBITDA broadly in line with expectationsRevenue guidance adjusted; R&D and adjusted EBITDA guidance unchanged, reflecting improved revenue mix and cost disciplineEvotec confirms itsOutlook 2028
Evotec SE Adjusts Revenue Guidance while Confirming Profit Guidance
HAMBURG, DE / ACCESS Newswire / July 21, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ:EVO) announces that it has updated its revenue guidance for the fiscal year 2025. Guidance on R&D expenses and adjusted EBITDA remains unchanged.
Onco-Innovations Appoints Dr. Dennis Hall to Scientific & Clinical Advisory Board
VANCOUVER, BC / ACCESS Newswire / July 21, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(Frankfurt:W1H)(WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce the appointment of Dr. Dennis Hall, Professor of Chemistry at the University of Alberta, to its Scientific and Clinical Advisory Board.
Pope calls Buzz Aldrin to mark 1969 moon landing
Pope Leo XIV on Sunday called astronaut Buzz Aldrin and visited the Vatican's astronomical observatory in Castel Gandolfo to mark the 56th anniversary of man's first moon landing.
Arrested Kenyan activist faces terror charges
Renowned Kenyan rights activist Boniface Mwangi is accused of "facilitation of terrorist acts" during protests that rocked the country last month, investigators said on Sunday, a day after he was arrested.
Lesotho's jockeys saddle up for mountain horse racing
Swathed in vibrant woollen blankets against the biting winter chill, jockeys -- some no more than boys -- thundered down a dusty track carved between the undulating hills of the tiny kingdom of Lesotho.
Texas flood missing toll revised sharply down to three
Authorities in Texas have sharply lowered the number of people still believed missing after catastrophic flooding earlier this month, saying the search continued for three individuals in the worst-hit area of the US state.
South Korea rain death toll hits 17, with 11 missing
Heavy rain in South Korea has killed at least 17 people in recent days, government records showed Sunday, while 11 remain unaccounted for in the intense downpours.
South Korea rain death toll rises to 14: government
At least two people were killed during heavy downpours in South Korea Sunday, the interior ministry said, bringing the death toll to 14 from torrential rains this week.
Tearful relatives await news from Vietnam wreck rescue
Relatives anxiously sat beside ambulances on the wharf of one of Vietnam's most popular tourist sites on Sunday, waiting for news of loved ones who were on a tourist boat that capsized killing dozens.
Driver charged after plowing into Los Angeles nightclub crowd, injuring 30
A driver was charged with assault after plowing into a crowd outside a Hollywood nightclub early Saturday, police said, injuring 30 people, with bystanders attacking and shooting the driver before he was detained by authorities.
Sunbears to elephants: life at a Thai wildlife hospital
The patient lay prone on the operating table. An IV line snaking from his left leg, near the wound from the tranquilliser dart that sedated him.
DEA's Cannabis Cartel: A Federal Marijuana Scam That Sabotaged Science, Blocked Patients, and Protected Power
As thousands suffer without access to FDA-approved cannabis treatments, MMJ BioPharma Cultivation is waging a David vs. Goliath legal war against the DEA's decade-long deception-and incoming Administrator Terrance Cole must decide whether to continue the cover-up or finally put patients over politics.
Bid to bring back pesticide in France sparks unprecedented petition
A new law in France allowing the reintroduction of a banned pesticide has sparked a record-breaking petition opposing it, which on Saturday had gathered more than 500,000 signatures.
Ceasefire order fails to halt fighting in Syria's Druze heartland
Syrian Bedouin and their allies fought Druze fighters in the community's Sweida heartland for a seventh day Saturday despite a ceasefire ordered by the government following a US-brokered deal to avert further Israeli military intervention.
Bangladesh's largest Islamist party holds mega rally
Hundreds of thousands of supporters of Bangladesh's main Islamist party rallied on Saturday, demanding an overhaul of the electoral system as the country gears up for polls next year.